CV-MG01

· CuraVac

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CV-MG01, covering 2019-01-28 to 2019-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis [Phase 1, Phase 2]